Entourage Health Corp. (formerly WeedMD Inc.)
(
TSX-V:ENTG)
(OTCQX:ETRGF)
(FSE:4WE) (“
Entourage” or the
“
Company”), a Canadian producer and distributor of
award-winning cannabis products and brands, is pleased to announce
it has strengthened its executive team with key strategic
appointments in the areas of commercial sales, marketing, and
business development as well as product development, cultivation
and supply chain. Concurrent with the recent closing of the
Company’s acquisition of renowned craft cultivator CannTx Life
Sciences Inc. (“CannTx”), Entourage announces the following:
Joseph Mele is appointed
Chief Commercial Officer. Most recently the Senior
Vice President of Commercial Sales and Marketing at Entourage,
Joseph oversees all revenue-generating commercial roles and
activities. Under his leadership, Entourage increased adult-use and
medical sales by over 150 per cent, and his team is credited with
expanding its brand’s market share points by over 75 per cent
during the past year. Joseph also leads the business development
team.
Pat Scanlon, co-founder of
CannTx is appointed Head of Cultivation across all
Company sites. Pat has over 15 years of experience in floriculture,
commercial greenhouse operations and specializes in craft-grade
cultivation, production and phenotyping. As Entourage looks to
expand its craft cannabis operations and product development, Pat
will oversee the Company’s genetics activities and introduce new
cultivars and craft practices.
James Afara is appointed
Vice President of Strategic Sourcing and
Purchasing. Former Chief Operating Officer of CannTx,
James has extensive experience in supply chain, business analytics
and operations management. A professional engineer by trade, he
brings strong industry metrics analysis and supplier relationships
that will be integral to Entourage’s ability to scale.
“As we complete our final integration steps with
CannTx, it is vital that we continue to build a strong cohesive
team backed by proven leadership to execute and meet our strategic
growth targets - and I’m thrilled to announce the appointments of
Joe, Pat and James,” said George Scorsis, Interim CEO and Executive
Chairman, Entourage. “This team of experts will further strengthen
our leadership team at this pivotal time in our business
transformation. We are driving synergies throughout our
organization as we diversify our product pipeline with new
genetics, new product formats, new supply-chain partners and a
robust sales distribution network that will expand the reach of our
Color Cannabis, Saturday Cannabis, Starseed Medicinal and craft
brand Royal City Cannabis Co. across Canada. Entourage has recorded
consistent sequential revenue growth over the past four reporting
quarters and this team will ensure we continue to drive value and
scale for further growth.”
At this time, Entourage also extends its
gratitude to Jason Alexander, former Chief
Strategy Officer and Chief Legal Officer,
who was integral to the Company’s acquisition of both Starseed
Holdings Inc. (“Starseed”) and CannTx, as well as
Entourage’s growth and success over the past year. Jason has
elected to step down from the management team, however the Company
is pleased to confirm he will continue as a board director and head
of the Governance Committee.
Additional information about Entourage’s current
management team can be found here. Visit Entourage Health’s newly
launched website here. To access our corporate video, visit us here
and to access our latest investor presentation and corporate deck
here.
About Entourage Health
Corp.
Entourage Health Corp. (formerly WeedMD Inc.) is
the publicly traded parent company of WeedMD RX Inc. and CannTx
Life Sciences Inc., licence holders producing and distributing
cannabis products for both the medical and adult-use markets. The
Company owns and operates a 158-acre state-of-the-art greenhouse,
outdoor and processing facility located in Strathroy, ON as well as
a fully licensed 26,000 sq. ft. Aylmer, ON processing facility,
specializing in cannabis extraction. With the addition of Starseed
Medicinal, a medical-centric brand, Entourage has expanded its
multi-channeled distribution strategy. Starseed’s industry-first,
exclusive partnership with LiUNA, the largest construction union in
Canada, along with employers and union groups complements
Entourage’s direct sales to medical patients. In October 2021,
Entourage closed the acquisition of craft cultivator CannTx Life
Sciences Inc. which operates out of its state-of-the-art
micropropagation and specialty extraction facility in Guelph,
Ontario. Craft brand Royal City Cannabis was added to Entourage’s
elite product portfolio that includes adult-use brands Color
Cannabis and Saturday Cannabis – sold across eight provincial
distribution agencies. The Company also maintains strategic
relationships in the seniors’ market and supply agreements with
Shoppers Drug Mart. It is the exclusive Canadian producer and
distributor of award-winning U.S.-based wellness brand Mary’s
Medicinals sold in both medical and adult-use channels. Entourage
recently announced an exclusive collaboration with The Boston Beer
Company subsidiary to launch cannabis-infused beverages in Canada
with production expected in Q4, 2021 and product launch in early
2022.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on
LinkedIn
Twitter: Entourage,
Color Cannabis, Saturday
Cannabis, Starseed
& Royal City Cannabis Co.
Instagram:
Entourage, Color
Cannabis, Saturday
Cannabis, Starseed
& Royal City Cannabis Co.
For further information, please
contact:
For Investor Enquiries:Valter
PintoManaging Director KCSA Strategic
Communications1-212-896-1254entourage@kcsa.com
For Media Enquiries:Marianella
delaBarreraSVP, Communications & Corporate
Affairs416-897-6644marianella@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies, including the successful
integration of CannTx and execution of its strategic partnerships;
the COVID-19 pandemic; competition; crop failure; and other
risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024